Aller au contenu

Safety and antitumor activity of a-PD-L1 antibody as monotherapy or in combination with a-TIM-3 antibody in patients with microsatellite instability-high/mismatch repair-deficient tumors

Nom du journal : Clin Cancer Res

Année : 2021

Volume : 27

Page de départ : 6393

Page de fin : 6404

Auteurs: Yu D, Lin CC, Bang YJ, Chung HC, Machiels JP, Moreno V, Hollebecque A, Italiano A, de Miguel MJ, Dhani NC, Peeters M, Su WC, Chow KH, Galvao VR, Carlsen M, Szpurka AM, Zhao Y, Schmidt SL, Gandhi L, Xu X,